Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Weight-loss drugs like Ozempic may be up for Medicare price negotiations — will Trump support it?
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face an uncertain future in the incoming Trump administration.
UK's Fundsmith says it shed Diageo over management issues, weight loss drugs
Britain's Terry Smith made public for the first time on Thursday why his fund dumped its Diageo stake last year, citing problems with its new management and early signs that weight loss drugs threatened the drinks sector.
I’m a weight-loss doctor — the unusual complication I’m seeing from Ozempic-like drugs
A top NYC weight-loss doctor shared the surprising skin complication that he’s encountered in patients using GLP-1 drugs like Ozempic.
Ozempic ‘microdosing’ is the new weight-loss trend: Should you try it?
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts weigh the pros and cons of the practice.
‘Ozempic’s biggest night’: How weight loss drugs showed up at the 2025 Golden Globes
Just eight seconds into the start of the 2025 award show season, Nikki Glaser, the host of the 82nd Golden Globes, dubbed the show “Ozempic’s biggest night.” The comedian wasn’t joking. She’s following the lead of Jimmy Kimmel,
Ozempic 3.0? This drug causes the greatest weight loss — by far
Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective for obese adults who do not have diabetes.
Less than 50% of employers cover GLP-1 drugs for weight loss: JPM survey
"Coverage for these weight-loss drugs has significant cost implications for employers, as a previous KFF analysis estimated that almost 50 million adults in employer plans meet the clinical criteria for taking such drugs, which can cost thousands of dollars annually per person," according to a report from Kaiser Family Health (KFF) in October.
As demand for weight-loss drugs rises, states grapple with Medicaid coverage
Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on Medicaid and have become yo-yo dieters who, despite their best efforts at changing their eating habits and lifestyles,
23h
Polls On Weight Loss And Will Power
Polls provide a useful window into understanding how Americans view their own weight and the recent availability of drugs ...
2h
16 Ways to Stay Motivated to Lose Weight in 2025
We’ve all been there — feeling super inspired about a new weight loss meal plan or workout routine. You’re crushing it day ...
2h
on MSN
Terry Smith Sells Diageo Stock on Concern Over Weight-Loss Drugs
British fund manager Terry Smith has sold his stake in Diageo Plc, citing concerns about the management of the drinks company ...
2h
AquaSculpt Reviews (Ice Water Hack) Best Diet Pills for Weight Loss in 2025
AquaSculpt is a breakthrough weight reduction product that claims to change the way people think about losing weight.
38m
From A to Ozempic: What you need to know about weight loss drugs and if they work - The Little Things
Weight loss drugs have risen in popularity in the recent years, but a disconnect remains between those who need the drugs and ...
2h
on MSN
Why People Swear The ‘50/50’ Workout Is the Ideal Pairing for Weight Loss
An expert shares everything to know about the "50/50" workout and why it's the perfect blend of cardio and strength training ...
5h
on MSN
Real-Life Weight Loss Story: 30 Kgs Down! This Couple’s Transformation Is Giving Major Fitness Goals
Himanshu Thakur and Chinchak Satapathy redefine "couple goals" by achieving a remarkable weight-loss transformation together.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Trump
Ozempic
Jonathan Van Ness
Wegovy
Novo Nordisk
Feedback